지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.12
- 수록면
- 94 - 94 (1page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
Gut and Liver
2021 .01
-
The Role of Neoadjuvant FOLFIRINOX Treatment on Conversion Surgery in Locally Advanced Pancreatic Cancer
대한외과학회 학술대회 초록집
2021 .05
-
Metastatic Pancreatic Carcinoma and Experience with FOLFIRINOX - a Cross Sectional Analysis From a Developing Country
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Complete response of locally advanced left-sided pancreatic cancer after modified FOLFIRINOX chemotherapy followed by conversion surgery: A case report
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .08
-
Treatment options for stable locally advanced pancreatic cancer after chemotherapy
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
A phase 2 trial of neoadjuvant modified folfirinox chemotherapy for resectable pancreatic adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
Gut and Liver
2021 .01
-
Clinical Outcomes of the Borderline Resectable Pancreatic Cancer according to the Neoadjuvant Chemo-Regimens: Gemcitabine vs. FOLFIRINOX
대한외과학회 학술대회 초록집
2019 .10
-
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
-
Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer
Annals of Surgical Treatment and Research
2017 .10
-
Pancreaticoduodenectomy with combined hepatic artery and portal vein resection after laparoscopic division of pancreaticosplenic ligament due to FOLFIRINOX-induced hepatic toxicity related secondary hypersplenism
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
-
Conversion surgery following neoadjuvant therapy for advanced biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Extended distal pancreatectomy with thoracic wall resection after neoadjuvant FOLFIRINOX: Is there a limit of resection for pancreatic cancer after downstaging?
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .02
-
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
-
Current status of neoadjuvant therapy for pancreas cancer
대한임상종양학회 학술대회지
2021 .06
-
Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .11
-
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
-
Neoadjuvant chemotherapy followed by total pancreatectomy with splenectomy and combined vascular resections after preoperative percutaneous transhepatic portal vein stent placement in locally advanced pancreatic cancer with portal vein total obliteration
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .11
-
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0